NEUPATH HEALTH INC (NPTH.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:NPTH - CA64133P1009 - Common Stock
0.51 CAD
0 (0%)
Taking everything into account, NPTH scores 3 out of 10 in our fundamental rating. NPTH was compared to 15 industry peers in the Health Care Providers & Services industry. The financial health of NPTH is average, but there are quite some concerns on its profitability. NPTH has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
NPTH had negative earnings in the past year.
NPTH had a positive operating cash flow in the past year.
In the past 5 years NPTH always reported negative net income.
Of the past 5 years NPTH 4 years had a positive operating cash flow.
1.2 Ratios
NPTH's Return On Assets of -1.20% is in line compared to the rest of the industry. NPTH outperforms 46.67% of its industry peers.
NPTH has a Return On Equity (-2.63%) which is in line with its industry peers.
NPTH has a better Return On Invested Capital (5.06%) than 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.2% | ||
| ROE | -2.63% | ||
| ROIC | 5.06% |
ROA(3y)-3.74%
ROA(5y)-5.69%
ROE(3y)-7.64%
ROE(5y)-10.74%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Operating Margin of NPTH (2.76%) is comparable to the rest of the industry.
With a Gross Margin value of 19.25%, NPTH is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of NPTH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.76% | ||
| PM (TTM) | N/A | ||
| GM | 19.25% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y-1.04%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NPTH is destroying value.
Compared to 1 year ago, NPTH has about the same amount of shares outstanding.
The number of shares outstanding for NPTH has been increased compared to 5 years ago.
The debt/assets ratio for NPTH has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.90 indicates that NPTH is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.90, NPTH is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
The Debt to FCF ratio of NPTH is 4.69, which is a neutral value as it means it would take NPTH, 4.69 years of fcf income to pay off all of its debts.
NPTH has a better Debt to FCF ratio (4.69) than 73.33% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that NPTH is somewhat dependend on debt financing.
NPTH has a Debt to Equity ratio of 0.56. This is amongst the best in the industry. NPTH outperforms 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 4.69 | ||
| Altman-Z | 1.9 |
ROIC/WACC0.72
WACC7.07%
2.3 Liquidity
A Current Ratio of 1.12 indicates that NPTH should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.12, NPTH belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
NPTH has a Quick Ratio of 1.12. This is a normal value and indicates that NPTH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.12, NPTH belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 34.21% over the past year.
The Revenue has grown by 18.67% in the past year. This is quite good.
NPTH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.96% yearly.
EPS 1Y (TTM)34.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.97%
Revenue 1Y (TTM)18.67%
Revenue growth 3Y6.16%
Revenue growth 5Y7.96%
Sales Q2Q%25.79%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.77%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for NPTH. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NPTH is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
NPTH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NPTH is cheaper than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.98 | ||
| EV/EBITDA | 8.08 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NPTH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX-V:NPTH (1/12/2026, 7:00:00 PM)
0.51
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners10.95%
Inst Owner ChangeN/A
Ins Owners2.56%
Ins Owner ChangeN/A
Market Cap28.64M
Revenue(TTM)83.93M
Net Income(TTM)-553.00K
Analysts80
Price Target0.51 (0%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.78%
Min Revenue beat(2)10.97%
Max Revenue beat(2)20.6%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)17.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.34 | ||
| P/FCF | 9.98 | ||
| P/OCF | 7.62 | ||
| P/B | 1.36 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.08 |
EPS(TTM)-0.01
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)0.05
FCFY10.02%
OCF(TTM)0.07
OCFY13.12%
SpS1.49
BVpS0.37
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.2% | ||
| ROE | -2.63% | ||
| ROCE | 7.03% | ||
| ROIC | 5.06% | ||
| ROICexc | 5.89% | ||
| ROICexgc | 23.5% | ||
| OM | 2.76% | ||
| PM (TTM) | N/A | ||
| GM | 19.25% | ||
| FCFM | 3.42% |
ROA(3y)-3.74%
ROA(5y)-5.69%
ROE(3y)-7.64%
ROE(5y)-10.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y-1.04%
F-Score6
Asset Turnover1.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 4.69 | ||
| Debt/EBITDA | 2.53 | ||
| Cap/Depr | 38.3% | ||
| Cap/Sales | 1.06% | ||
| Interest Coverage | 7.09 | ||
| Cash Conversion | 81.07% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.9 |
F-Score6
WACC7.07%
ROIC/WACC0.72
Cap/Depr(3y)39.19%
Cap/Depr(5y)26.48%
Cap/Sales(3y)1.5%
Cap/Sales(5y)1.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.97%
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.67%
Revenue growth 3Y6.16%
Revenue growth 5Y7.96%
Sales Q2Q%25.79%
Revenue Next Year22.77%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y103.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year308.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.94%
FCF growth 3Y3.23%
FCF growth 5YN/A
OCF growth 1Y20.57%
OCF growth 3Y10.75%
OCF growth 5YN/A
NEUPATH HEALTH INC / NPTH.CA FAQ
Can you provide the ChartMill fundamental rating for NEUPATH HEALTH INC?
ChartMill assigns a fundamental rating of 3 / 10 to NPTH.CA.
Can you provide the valuation status for NEUPATH HEALTH INC?
ChartMill assigns a valuation rating of 2 / 10 to NEUPATH HEALTH INC (NPTH.CA). This can be considered as Overvalued.
What is the profitability of NPTH stock?
NEUPATH HEALTH INC (NPTH.CA) has a profitability rating of 3 / 10.
What is the expected EPS growth for NEUPATH HEALTH INC (NPTH.CA) stock?
The Earnings per Share (EPS) of NEUPATH HEALTH INC (NPTH.CA) is expected to grow by 100% in the next year.